Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
Authors:
- Thomas EbensenTEThomas Ebensen
- Rimma LibanovaRLRimma Libanova
- Kai SchulzeKSKai Schulze
- Tetyana YevsaTYTetyana Yevsa
- Michael MorrMMMichael Morr
- Carlos A. GuzmánCarlos A. Guzmán
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- The role of Th17 cytokines in primary mucosal immunityCytokine & Growth Factor Reviews, 2010
- c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon ResponseScience, 2010
- Th17 cytokines and vaccine-induced immunitySeminars in Immunopathology, 2010
- A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMPJournal of Experimental Medicine, 2009
- c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infectionVaccine, 2008
- Structural Biochemistry of a Bacterial Checkpoint Protein Reveals Diadenylate Cyclase Activity Regulated by DNA Recombination IntermediatesMolecular Cell, 2008
- Oral Vaccination withSalmonella entericaas a Cruzipain-DNA Delivery System Confers Protective Immunity againstTrypanosoma cruziInfection and Immunity, 2008
- Cyclic Di-GMP Stimulates Protective Innate Immunity in Bacterial PneumoniaInfection and Immunity, 2007
- The Bacterial Second Messenger cdiGMP Exhibits Promising Activity as a Mucosal AdjuvantClinical and Vaccine Immunology, 2007
- 3′,5′-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferationBiochemical and Biophysical Research Communications, 2005